Advertisement

Specialized Care for Women: the Impact of Women’s Heart Centers

  • Gina P. Lundberg
  • Laxmi S. Mehta
  • Annabelle S. Volgman
Women’s Health (M Wood, Section Editor)
  • 12 Downloads
Part of the following topical collections:
  1. Topical Collection on Women’s Health

Abstract

Purpose of the review

Cardiovascular disease (CVD) has been and remains the leading cause of mortality in women in the United States. For decades, more women died every year of CVD compared to men. Heart centers for women (HCW) are developed in response to the need for greater patient and physician awareness of CVD in women and to conduct sex-specific research in women. Today, many HCW provide multispecialty and focused areas of cardiovascular care for women. HCW provide their female patients with expertise over the many stages of a woman’s life. And HCW partner with national organizations to advance research and education through specialized and focused care for women. The purpose of this review is to review the historical development of heart centers for women and discuss the types of care they provide for women.

Recent findings

Mortality rates from cardiovascular disease in women are finally reaching the levels of men after decades of focus on awareness, prevention, and evidence-based guideline-directed care for women.

Summary

Heart centers for women have evolved to provide subspecialty and comprehensive care for women that includes education and research. Heart centers for women are partnering with many other disease-based and patient advocacy organizations to provide care for all women at all stages of life. Alarmingly, there has been increasing CVD mortality in both men and women recently.

Keywords

Women Cardiovascular disease Prevention Disparities Heart centers for women Specialized care 

Abbreviations

AD

Alzheimer’s disease

AHA

American Heart Association

CAD

coronary artery disease

CDC

Centers for Disease Control and Prevention

CI

cognitive impairment

CV

cardiovascular

CVD

cardiovascular disease

FH

familial hypercholesterolemia

HCW

heart centers for women

Lp(a)

lipoprotein(a)

MHT

menopausal hormone therapy

NHLBI

National Heart, Lung, and Blood Institute

SCAD

spontaneous coronary artery dissection

US

United States

WISEWOMAN

Well-Integrated Screening and Evaluation for WOMen Across the Nation

Notes

Compliance with Ethical Standards

Conflict of Interest

The authors declare that they have no conflicts of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

References and Recommended Reading

  1. 1.
    Mosca L, Jones WK, King KB, Ouyang P, Redberg RF, Hill MN. Awareness, perception, and knowledge of heart disease risk and prevention among women in the United States. American Heart Association Women’s Heart Disease and Stroke Campaign Task Force. Arch Fam Med. 2000;9(6):506–15.CrossRefPubMedGoogle Scholar
  2. 2.
    Mosca L, Manson JE, Sutherland SE, Langer RD, Manolio T, Barrett-Connor E. Cardiovascular disease in women: a statement for healthcare professionals from the American Heart Association. Writing Group. Circulation. 1997;96(7):2468–82.CrossRefPubMedGoogle Scholar
  3. 3.
    Mosca L, Linfante AH, Benjamin EJ, Berra K, Hayes SN, Walsh BW, et al. National study of physician awareness and adherence to cardiovascular disease prevention guidelines. Circulation. 2005;111(4):499–510.CrossRefPubMedGoogle Scholar
  4. 4.
    Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA. 1998;280(7):605–13.CrossRefPubMedGoogle Scholar
  5. 5.
    Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial. JAMA. 2002;288(3):321–33.CrossRefPubMedGoogle Scholar
  6. 6.
    Benjamin EJ, Virani SS, Callaway CW, Chamberlain AM, Chang AR, Cheng S, et al. Heart disease and stroke statistics—2018 update: a report from the American Heart Association. Circulation. 2018;137(12):e67–e492.CrossRefPubMedGoogle Scholar
  7. 7.
    Mosca L, Appel LJ, Benjamin EJ, Berra K, Chandra-Strobos N, Fabunmi RP, et al. Evidence-based guidelines for cardiovascular disease prevention in women. Circulation. 2004;109(5):672–93.CrossRefPubMedGoogle Scholar
  8. 8.
    Disease WTNCfWwH. National directory of women’s heart center. 2001.Google Scholar
  9. 9.
    Mosca L, Benjamin EJ, Berra K, Bezanson JL, Dolor RJ, Lloyd-Jones DM, et al. Effectiveness-based guidelines for the prevention of cardiovascular disease in women—2011 update: a guideline from the American Heart Association. Circulation. 2011;123(11):1243–62.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Mosca L, Mochari-Greenberger H, Dolor RJ, Newby LK, Robb KJ. Twelve-year follow-up of American women’s awareness of cardiovascular disease risk and barriers to heart health. Circ Cardiovasc Qual Outcomes. 2010;3(2):120–7.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Mosca L, Hammond G, Mochari-Greenberger H, Towfighi A, Albert MA. Fifteen-year trends in awareness of heart disease in women: results of a 2012 American Heart Association national survey. Circulation 2013;127(11):1254–1263, e1-29.Google Scholar
  12. 12.
    Bairey Merz CN, Andersen H, Sprague E, Burns A, Keida M, Walsh MN, et al. Knowledge, attitudes, and beliefs regarding cardiovascular disease in women: the Women’s Heart Alliance. J Am Coll Cardiol. 2017;70:123–32.CrossRefPubMedGoogle Scholar
  13. 13.
    Barnhart J, Lewis V, Houghton JL, Charney P. Physician knowledge levels and barriers to coronary risk prevention in women: survey results from the Women and Heart Disease Physician Education Initiative. Womens health issues. 2007;17:93-100.Google Scholar
  14. 14.
    Garcia M, Miller VM, Gulati M, Hayes SN, Manson JE, Wenger NK, et al. Focused cardiovascular care for women: the need and role in clinical practice. Mayo Clin Proc. 2016;91(2):226–40.CrossRefPubMedGoogle Scholar
  15. 15.
    Hirshberg A, Srinivas SK. Epidemiology of maternal morbidity and mortality. Seminars in Perinatology: WB Saunders; 2017.Google Scholar
  16. 16.
    Centers for Disease Control and Prevention. Reproductive health https://www.cdc.gov/reproductivehealth/maternalinfanthealth/pmss.html Published June 29, 2017 [October 22, 2017]. Available from: https://www.cdc.gov/reproductivehealth/maternalinfanthealth/pmss.html.
  17. 17.
    Collaborators GBDMM. Global, regional, and national levels of maternal mortality, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388(10053):1775–1812.Google Scholar
  18. 18.
    Roberts JM, Hubel CA. Pregnancy: a screening test for later life cardiovascular disease. Womens Health Issues. 2010;20(5):304–7.CrossRefPubMedGoogle Scholar
  19. 19.
    Launer LJ, Hughes T, Yu B, Masaki K, Petrovitch H, Ross GW, et al. Lowering midlife levels of systolic blood pressure as a public health strategy to reduce late-life dementia: perspective from the Honolulu Heart Program/Honolulu Asia Aging Study. Hypertension. 2010;55(6):1352–9.CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Ritchie K, Carriere I, Ritchie CW, Berr C, Artero S, Ancelin ML. Designing prevention programmes to reduce incidence of dementia: prospective cohort study of modifiable risk factors. BMJ. 2010;341:c3885.CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Barnes DE, Yaffe K. The projected effect of risk factor reduction on Alzheimer’s disease prevalence. Lancet Neurol. 2011;10(9):819–28.CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Alzheimer’s Association 2014 Alzheimer’s disease facts and figures. Alzheimers Dement: J Alzheimer’s Assoc. 2014;10(2):e47–92.Google Scholar
  23. 23.
    Garg AK, Verma P. Cardiovascular disease among South Asians. CMAJ : Can Med Assoc J = J Assoc Med Canadienne. 2010;182(12):1334. author replyCrossRefGoogle Scholar
  24. 24.
    Barac A, Murtagh G, Carver JR, Chen MH, Freeman AM, Herrmann J, et al. Cardiovascular health of patients with cancer and cancer survivors: a roadmap to the next level. J Am Coll Cardiol. 2015;65(25):2739–46.CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Chapman JA, Meng D, Shepherd L, Parulekar W, Ingle JN, Muss HB, et al. Competing causes of death from a randomized trial of extended adjuvant endocrine therapy for breast cancer. J Natl Cancer Inst. 2008;100(4):252–60.CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Hanrahan EO, Gonzalez-Angulo AM, Giordano SH, Rouzier R, Broglio KR, Hortobagyi GN, et al. Overall survival and cause-specific mortality of patients with stage T1a,bN0M0 breast carcinoma. J Clin Oncol. 2007;25(31):4952–60.CrossRefPubMedGoogle Scholar
  27. 27.
    Mehta LS, Watson KE, Barac A, Beckie TM, Bittner V, Cruz-Flores S, et al. Cardiovascular disease and breast cancer: where these entities intersect: a scientific statement from the American Heart Association. Circulation. 2018;137(8):e30–66.CrossRefPubMedGoogle Scholar
  28. 28.
    Shaw LJ, Butler J. Targeting priority populations to reduce disparities in cardiovascular care: health equity for all. J Am Coll Cardiol. 2014;64(4):346–8.CrossRefPubMedGoogle Scholar
  29. 29.
    Gilstrap LG, Malhotra R, Peltier-Saxe D, Slicas D, Pineda E, Culhane-Hermann C, et al. Community-based primary prevention programs decrease the rate of metabolic syndrome among socioeconomically disadvantaged women. Journal of women’s health (2002). 2013;22(4):322–9.CrossRefGoogle Scholar
  30. 30.
    Hayes SN, Wood SF, Mieres JH, Campbell SM, Wenger NK. Taking a giant step toward women’s heart health: finding policy solutions to unanswered research questions. Womens Health Issues. 2015;25(5):429–32.CrossRefPubMedGoogle Scholar
  31. 31.
    World Health Organization. Social determinants of health: women and gender equality. http://www.who.int/social_determinants/themes/womenandgender/en. World Health Organization, 2017 August 3, 2017. Report No.
  32. 32.
    Mehta LS, Beckie TM, DeVon HA, Grines CL, Krumholz HM, Johnson MN, et al. Acute myocardial infarction in women: a scientific statement from the American Heart Association. Circulation. 2016;133(9):916–47.CrossRefPubMedGoogle Scholar
  33. 33.
    Hayes SN, Kim ESH, Saw J, Adlam D, Arslanian-Engoren C, Economy KE, et al. Spontaneous coronary artery dissection: current state of the science: a scientific statement from the American Heart Association. Circulation. 2018;137:e523–57.CrossRefPubMedPubMedCentralGoogle Scholar
  34. 34.
    Kostakou PM, Hatzigeorgiou G, Kolovou V, Mavrogeni S, Kolovou GD. Lipoprotein (a) evolution: possible benefits and harm. Genetic and non-genetic factors influencing its plasma levels. Curr Med Chem. 2017;24(10):969–78.CrossRefPubMedGoogle Scholar
  35. 35.
    Shlipak MG, Simon JA, Vittinghoff E, Lin F, Barrett-Connor E, Knopp RH, et al. Estrogen and progestin, lipoprotein (a), and the risk of recurrent coronary heart disease events after menopause. JAMA. 2000;283(14):1845–52.CrossRefPubMedGoogle Scholar
  36. 36.
    Suk Danik J, Rifai N, Buring JE, Ridker PM. Lipoprotein(a), hormone replacement therapy, and risk of future cardiovascular events. J Am Coll Cardiol. 2008;52(2):124–31.CrossRefPubMedPubMedCentralGoogle Scholar
  37. 37.
    Costello BT, Silverman ER, Doukky R, Braun LT, Aggarwal NT, Deng Y, et al. Lipoprotein(a) and increased cardiovascular risk in women. Clin Cardiol. 2016;39(2):96–102.CrossRefPubMedGoogle Scholar
  38. 38.
    Wong B, Kruse G, Kutikova L, Ray KK, Mata P, Bruckert E. Cardiovascular disease risk associated with familial hypercholesterolemia: a systematic review of the literature. Clin Ther. 2016;38(7):1696–709.CrossRefPubMedGoogle Scholar
  39. 39.
    Kjaergaard KA, Christiansen MK, Schmidt M, Olsen MS, Jensen HK. Long-term cardiovascular risk in heterozygous familial hypercholesterolemia relatives identified by cascade screening. J Am Heart Assoc. 2017;6(6):e005435.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  • Gina P. Lundberg
    • 1
  • Laxmi S. Mehta
    • 2
  • Annabelle S. Volgman
    • 3
  1. 1.Emory Women’s Heart CenterEmory University School of MedicineAtlantaUSA
  2. 2.Women’s Cardiovascular ProgramThe Ohio State UniversityColumbusUSA
  3. 3.Rush Heart Center for WomenRush University Medical CenterChicagoUSA

Personalised recommendations